Trial of Pentostatin Plus Cyclophosphamide With Ofatumumab (PCO) in Older Patients With Chronic Lymphocytic Leukemia
Status:
Completed
Trial end date:
2016-12-01
Target enrollment:
Participant gender:
Summary
This is a phase II multicenter, non-comparative, open label study in older previously
untreated Chronic Lymphocytic Leukaemia patients, requiring therapy, aimed at defining the
efficacy profile (ORR, CRR and TTP) of pentostatin and cyclophosphamide given in combination
with Ofatumumab (PCO).
Phase:
Phase 2
Details
Lead Sponsor:
Niguarda Hospital
Collaborators:
GlaxoSmithKline Hospira, Inc. Hospira, now a wholly owned subsidiary of Pfizer Regione Lombardia